NIT Warangal has signed a technology transfer agreement with MOHSoft Tech Private Limited to commercialise an indigenous ozone disinfection technology developed by researchers in the institute’s Department of Physics.
The agreement gives MOHSoft the rights to manufacture, scale up and commercialise products based on the technology in domestic and international markets. The two organisations will also collaborate on further research and development.
According to the researchers, the technology uses ozone’s natural oxidising properties to eliminate up to 99.9% of viruses, bacteria and other pathogens under specified operating conditions. Ozone decomposes into oxygen after use, they said, reducing concerns associated with chemical residues found in conventional disinfectants.
The technology transfer places a laboratory-developed disinfection system within a commercialisation framework. For cities and public institutions, such systems are relevant to the wider challenge of maintaining effective sanitation while managing the handling and residual effects of chemical disinfectants. However, the institute’s stated performance figure is conditional on the technology being used under specified operating conditions.
“Translating research outcomes into technologies that address real-world challenges is an important part of our institutional vision. This collaboration will help take an indigenously developed technology beyond the laboratory and create opportunities for its wider adoption across sectors,” said Bidyadhar Subudhi, director of NIT Warangal.
D Harnath, one of the inventors, said the technology emerged from research into the properties of ozone and was developed as an effective, sustainable and indigenous disinfection solution. The focus now, he said, is on refining the technology, scaling it up and making it commercially viable.
The agreement does not specify in the supplied announcement which products will be manufactured first, the sectors that will receive priority or the timeline for commercial availability. It also does not provide details on the proposed manufacturing capacity, pricing, regulatory approvals or independent performance testing.
The collaboration’s immediate next steps are further research and development, alongside MOHSoft’s work to manufacture, scale up and commercialise the technology for domestic and international markets.
